Zobrazeno 1 - 10
of 627
pro vyhledávání: '"Z-drugs"'
Publikováno v:
International Journal of Qualitative Studies on Health & Well-Being, Vol 19, Iss 1 (2024)
Introduction Treatment for substance use disorder (SUD) to benzodiazepine receptor agonists (BZRA) can be challenging and lengthy. BZRA are prescribed for anxiety and insomnia, and though guidelines recommend an initial prescription duration of one t
Externí odkaz:
https://doaj.org/article/ae4befb4176b42ebb8abcd232a4bfe3b
Autor:
Andrea L. Murphy, Korolos Sawires, Sophie M. Peltekian, Melissa Helwig, Marilyn Macdonald, Ruth Martin-Misener, Bandana Saini, Heather Neyedli, Chris Giacomantonio, David M. Gardner
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 16, Iss , Pp 100538- (2024)
Background: Benzodiazepines and Z-drugs (e.g., zopiclone, zolpidem) (benzodiazepine receptor agonists or BZRAs), are prescribed for anxiety and insomnia disorders. However, they are not indicated as first line therapies for long-term management due t
Externí odkaz:
https://doaj.org/article/587d1be4de564b02845f1dedb0b42f3f
Autor:
Fabiana Carvalho, André Comiran Tonon, Maria Paz Hidalgo, Manuela Martins Costa, Sotero Serrate Mengue
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
ObjectiveThe study aimed to evaluate Zolpidem and Benzodiazepines prescription and dispensing data in private pharmacies in Brazil from 2014 to 2021. Methods: This retrospective cohort study was carried out with retrospective open data from the Brazi
Externí odkaz:
https://doaj.org/article/150c4b3b7e84486b8c84542b09caaf1b
Publikováno v:
Child and Adolescent Psychiatry and Mental Health, Vol 18, Iss 1, Pp 1-10 (2024)
Abstract Background The COVID-19 pandemic has posed challenges that worsened people’s mental health. We explored the impact of the COVID-19 pandemic on the mental well-being of the population, as indicated by the prevalence rates of benzodiazepine
Externí odkaz:
https://doaj.org/article/687af00fb15449c4b7c1d449d396484a
Autor:
Hanna Särkilä, Heidi Taipale, Antti Tanskanen, Terhi Kurko, Tero Taiminen, Jari Tiihonen, Reijo Sund, Leena Saastamoinen, Jarmo Hietala, Solja Niemelä
Publikováno v:
BJPsych Open, Vol 10 (2024)
Background A nationwide register-based cohort study from Finland including 48 124 incident benzodiazepines and related drug (BZDR) users aged 18–65 years who initiated use in 2006 and were not dispensed BZDRs during 2004–2005. The follow-up was 5
Externí odkaz:
https://doaj.org/article/fb969995c2b64ba9b743790017907e7b
Autor:
Louise Durand, Eamon Keenan, Deirdre O’Reilly, Kathleen Bennett, Andy O’Hara, Gráinne Cousins
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Pharmacotherapy is essential for the delivery of an equivalent standard of care in prison. Prescribing can be challenging due to the complex health needs of prisoners and the risk of misuse of prescription drugs. This study examin
Externí odkaz:
https://doaj.org/article/e9f5e2c02ed0471da1dbcb28e36232e7
Autor:
Lorenz Van der Linden, Julie Hias, Astrid Liesenborghs, Karolien Walgraeve, Pieter Van Brantegem, Laura Hellemans, Koen Milisen, Jos Tournoy
Publikováno v:
BMC Geriatrics, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Chronic use of hypnotic agents is prevalent in older adults, who as a result are at increased risk for certain adverse events, such as day-time drowsiness and falls. Multiple strategies to discontinue hypnotics have been tested in
Externí odkaz:
https://doaj.org/article/d9330b3ce7644bdabef8a5e02ebfd79b
Publikováno v:
Health Expectations, Vol 27, Iss 1, Pp n/a-n/a (2024)
Abstract Background Many individuals worldwide continue to take benzodiazepine receptor agonists (BZRAs) long term (≥3 months). The aim of this study was to conduct a content analysis of the views and experiences of discontinuing long‐term BZRA u
Externí odkaz:
https://doaj.org/article/955ec3d2058d4d0a99f65db053403f42
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background The Z-drugs are indicated for the short-treatment of insomnia, but they are associated with abuse, dependence and side-effects. There are only sparse data about Z-drug prescribing in Greece. Methods We analyzed data from the Greek
Externí odkaz:
https://doaj.org/article/274af1f512c647e49570a3b919fab115
Publikováno v:
Journal of Education, Health and Sport, Vol 46, Iss 1 (2023)
Benzodiazepines (BZDs) and Z-drugs are commonly prescribed medications for anxiety and sleep disorders. This review examines their efficacy, associated risks, and alternative treatment options. BZDs enhance the activity of gamma-aminobutyric acid (GA
Externí odkaz:
https://doaj.org/article/94298e3a67484306bdc6ca7c3a088f51